Clinical data of six patients
| Patients | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Age, years | 20 | 82 | 26 | 49 | 24 | 25 |
| Sex | Male | Male | Male | Male | Male | Female |
| Drug received by patient | Lamivudine | Lamivudine | Telbivudine | Telbivudine | Lamivudine | Telbivudine |
| Daily dose, mg | 100 | 100 | 600 | 600 | 100 | 600 |
| Duration of nucleotide analogues therapy before symptom onset, months | 12 | 12 | 12 | 24 | 48 | 12 |
| Interval between symptom onset and evaluation | 6 months | 2 months | 6 months | 12 months | 8 years | 1 month |
| Medication after diagnosis | Switched to entecavir | Discontinuance | Discontinuance | Switched to entecavir | Continued lamivudine | Switched to entecavir |
| Daily dose, mg | 0.5 | – | – | 0.5 | 100 | 0.5 |
| Recovery time, months | 3 | 3 | 3 | 3 | Not available | 1 |